Immunocore (IMCR) traded down -3.55 % during a 24 hours period ending at 03:52 AM Central Europe on Tuesday 27th. One Immunocore stock can currently be bought for about USD 31.28 on popular exchanges. Current supply of Immunocore stocks is 51.6 mn. Immunocore has a current market capitalization of USD 1.6 bn and approximately USD 5.5 mn worth of Immunocore was traded on exchanges in the last 24 hours. Since last month end, Immunocore has traded -0.99 % down. Simple moving average of last 200 days is at USD 31.8. The highest price of past 52 weeks was recorded at USD 40.72 on 12/05/2025. 52 weeks low was at USD 27.5 on 10/14/2026.

Here is how related stocks have performed in the past 24 hours:

  • Rolls-royce (RR.L) traded down -7.57 % and now trades at GBX 1,234.8. Rolls-royce has a market capitalisation of GBX 127.9 bn. Current price/earnings ratio for Rolls-royce is 32.29.

  • Unilever (ULVR.L) traded down -0.76 % and now trades at GBX 4,923. Unilever has a market capitalisation of GBX 143.4 bn. Unilever has a current price to earnings ratio of 24.2.

  • Capri (CPRI) traded down -3 % and now trades at USD 15.57. Capri has a market capitalisation of USD 1.8 bn. Capri has a current price to earnings ratio of 20.73.

  • Nomad Foods (NOMD) traded down -1.88 % and now trades at USD 11.85. Nomad Foods has a market capitalisation of USD 1.7 bn. Current price/earnings ratio for Nomad Foods is 12.39.

  • British American Tob (BATS.L) traded down -1.01 % and now trades at GBX 4,510. Current market capitalisation for British American Tob is GBX 127.9 bn. British American Tob has a current price to earnings ratio of 15.21.

About Immunocore

Immunocore Holdings PLC is a health care sector-based company with its operations centered in Abingdon, United Kingdom. The company serves two primary markets, the United Kingdom and the United States, and is listed on the Nasdaq stock exchange. Through its various subsidiaries, Immunocore Holdings develops and commercializes a new generation of transformative medicines aimed at addressing unmet needs in cancer, infection, and autoimmune diseases. This multinational organization strives to revolutionize the approach to these diseases by providing innovative solutions that cater to these specific health concerns.